Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are investigating if the presence of particular proteins, peptides and metabolites in serum constitutes diagnostic or prognostic biomarkers in Ankylosing Spondylitis (AS).

We will also describe the functional significance of differences between the serums of patients with AS, rheumatoid arthritis and healthy controls, as well as how these relate to gene expression data.

Funded by an Action Medical Research project grant.